All terms
Swissmedic
Swiss medical device regulator; Switzerland is now a third country to the EU under MDR.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
Swissmedic enforces the Swiss Medical Devices Ordinance (MedDO), which mirrors most of EU MDR. Since the EU-Swiss Mutual Recognition Agreement was not updated for MDR, manufacturers need a Swiss Authorized Representative (CH-REP) and Swiss-specific labeling. What the regulation says
Swissmedic is the Swiss Agency for Therapeutic Products, equivalent to the FDA in the United States or a national Competent Authority within the European Union. It is responsible for authorizing and supervising therapeutic products, including medical devices, in Switzerland. Swissmedic enforces the Medical Devices Ordinance (MedDO), which aligns with many principles of the EU Medical Devices Regulation (EU MDR), as outlined in Article 10 of MedDO.
What this means in practice
Often overlooked when planning EU launches; missing CH-REP or labeling routinely blocks Swiss commercialization.Examples
- A German manufacturer planning to sell a Class IIa device in Switzerland must appoint a CH-REP and ensure their device labeling includes the CH-REP's details and meets Swiss language requirements, even if it is fully CE-marked.
- An American company, already compliant with EU MDR, discovers during their Swiss market entry planning that they need to revise their instruction for use (IFU) and device labels to include specific Swiss-mandated symbols and information about their CH-REP.
- A MedTech startup developing innovative software as a medical device (SaMD) for both EU and Swiss markets allocates specific resources to understand and implement Swissmedic’s unique registration and post-market surveillance requirements, beyond their EU MDR efforts.
Common pitfalls
- •A common pitfall is assuming that EU MDR compliance alone is sufficient for market access in Switzerland, neglecting the specific Swiss requirements.
- •Manufacturers often overlook the need for a designated Swiss Authorized Representative (CH-REP) before placing devices on the Swiss market.
- •Failing to implement Swiss-specific labeling requirements, such as language and symbol variations, can lead to market access delays.
- •Confusion regarding the status of the EU-Switzerland Mutual Recognition Agreement (MRA) post-EU MDR implementation can result in non-compliance.
Frequently asked questions
Swissmedic is the national regulatory authority responsible for ensuring the safety and efficacy of medical devices marketed in Switzerland, overseeing their authorization and post-market surveillance activities.
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Regulatory
· Same categoryRegulatory
510(k) Premarket Notification(510(k))
FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
Regulatory
510(k) Summary vs 510(k) Statement
Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Regulatory
513(g) Request for Information(513(g))
Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.
Regulatory
Abbreviated 510(k)
510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards.
Primary references
3 sourcesLink health: 3 verified· last checked 2026-06-20
Swissmedic·1European Commission·1IMDRF·1
- 1
Swissmedic Medical DevicesVerifiedSwissmedicswissmedic.ch
- 2
European Commission - Medical DevicesVerifiedEuropean Commissionhealth.ec.europa.eu
- 3
IMDRF DocumentsVerifiedIMDRFimdrf.org
Inline markers like [1] jump to the matching reference above.